NEW YORK, June 10, 2021 /PRNewswire/ -- VG Acquisition
Corp. (NYSE: VGAC), a special purpose acquisition company sponsored
by Virgin Group ("VGAC" or the "Company") today announced that its
shareholders voted to approve the previously announced merger
agreement with 23andMe, Inc. ("23andMe") at VGAC's extraordinary
general meeting of shareholders (the "Special Meeting") held
earlier today.
More than 87% of the votes cast at the Special Meeting were in
favor of the approval of the merger agreement. VGAC
shareholders also voted overwhelmingly to approve the other
proposals presented at the Special Meeting.
As previously announced, the consummation of the business
combination with 23andMe is expected to occur on June 16, 2021, subject to the satisfaction of
customary closing conditions. Upon the closing, VGAC will
change its name to 23andMe Holding Co. ("New 23andMe"), and New
23andMe Class A common stock and New 23andMe warrants will be
listed on The Nasdaq Global Select Market ("Nasdaq"). Trading is
expected to begin on Nasdaq on June 17,
2021, under the new ticker symbol "ME" for the New 23andMe
Class A common stock and "MEUSW" for the New 23andMe warrants.
About 23andMe, Inc.
23andMe, Inc., headquartered in Sunnyvale, CA, is a leading
consumer genetics and research company. Founded in 2006, 23andMe's
mission is to help people access, understand, and benefit from the
human genome. 23andMe has pioneered direct access to genetic
information as the only company with multiple Food and Drug
Administration authorizations for genetic health risk reports.
23andMe has created the world's largest crowdsourced platform for
genetic research, with 80% of its customers electing to
participate. The 23andMe research platform has generated more than
180 publications on the genetic underpinnings of a wide range of
diseases, conditions, and traits. The platform also powers the
23andMe therapeutics group, currently pursuing drug discovery
programs rooted in human genetics across a spectrum of disease
areas, including oncology, respiratory, and cardiovascular
diseases, in addition to other therapeutic areas. More information
is available at www.23andMe.com.
About VG Acquisition Corp.
VG Acquisition Corp. was formed for the purpose of effecting a
merger, amalgamation, share exchange, asset acquisition, share
purchase, reorganization, or similar business combination with one
or more businesses. The management team includes: Sir Richard Branson, founder of VGAC, a renowned
global entrepreneur, and founder of the Virgin Group; Josh Bayliss, VGAC's Chief Executive Officer and
director, who is the Chief Executive Officer of the Virgin Group
and is responsible for the Virgin Group's strategic development,
licensing of the brand globally, and management of direct
investments on behalf of the Virgin Group in various companies
around the world; and Evan Lovell,
VGAC's Chief Financial Officer and director, who is the Chief
Investment Officer of the Virgin Group and is responsible for
managing the Virgin Group's investment team and portfolio in
North America. More information is
available at https://vgacquisition.com/.
Forward-Looking Statements
This communication contains certain "forward-looking statements"
including statements regarding the occurrence and anticipated
timing of the business combination between VGAC and 23andMe and
regarding the listing of shares of the combined company on Nasdaq.
The words "anticipate," "believe," "continue," "could," "estimate,"
"expect," "intends," "may," "might," "plan," "possible,"
"potential," "predict," "project," "should," "would," and similar
expressions may identify forward-looking statements, but the
absence of these words does not mean that a statement is not
forward-looking. The forward-looking statements contained herein
are based on VGAC's current expectations and beliefs concerning
future developments and their potential effects, but there can be
no assurance that these will be as anticipated. These
forward-looking statements involve a number of risks, uncertainties
(some of which are beyond the control of VGAC), or other
assumptions that may cause actual results or performance to be
materially different from those expressed or implied by these
forward-looking statements. These factors include, among others:
the inability to complete the business combination, including due
to the failure of closing conditions. Except as required by law,
VGAC does not undertake any obligation to update or revise any
forward-looking statements whether as a result of new information,
future events, or otherwise.
Contacts
Investor Relations:
23andMe
Sard Verbinnen & Co
23andMe-SVC@sardverb.com
VG Acquisition Corp.
FTI Consulting
US, Canada, South America, Australia – Antonia
Gray / Grace Altman
Antonia.Gray@fticonsulting.com / Grace.Altman@fticonsulting.com
UK, Middle East, Asia, Africa
– Charles Palmer
Charles.Palmer@fticonsulting.com
Media Relations:
23andMe
press@23andMe.com
Sard Verbinnen & Co
Paul Kranhold / John Christiansen / Chris Kittredge 23andMe-SVC@sardverb.com
VG Acquisition Corp.
FTI Consulting
US, Canada, South America, Australia – Antonia
Gray / Grace Altman
Antonia.Gray@fticonsulting.com / Grace.Altman@fticonsulting.com
UK, Middle East, Asia, Africa
– Charles Palmer
Charles.Palmer@fticonsulting.com
View original
content:http://www.prnewswire.com/news-releases/virgin-groups-vg-acquisition-corp-shareholders-approve-business-combination-with-23andme-inc-301310472.html
SOURCE VG Acquisition Corp.